Candidate surname
Other names
Total Marks
Centre Number
Candidate Number
Please check the examination details below before entering your candidate information
Pearson Edexcel 
International
Advanced Level
Thursday 7 May 2020
Paper Reference WBI11/01
Morning (Time: 1 hour 30 minutes)
Biology
International Advanced Subsidiary / Advanced Level
Unit 1: Molecules, Diet, Transport and Health
You must have:
Scientific calculator, ruler, HB pencil
*P62456A0132*
P62456A
©2020 Pearson Education Ltd.
1/1/1/
Turn over    
Instructions
•	Use black ink or ball‑point pen.
•	Fill in the boxes at the top of this page with your name,  
centre number and candidate number.
•	Answer all questions.
•	Answer the questions in the spaces provided  
– there may be more space than you need.
•	Show all your working in calculations and include units where 
appropriate.
Information
•	The total mark for this paper is 80.
•	The marks for each question are shown in brackets 
– use this as a guide as to how much time to spend on each question.
•	In questions marked with an asterisk (*), marks will be awarded for your ability 
to structure your answer logically, showing how the points that you make are 
related or follow on from each other where appropriate.
Advice
•	Read each question carefully before you start to answer it.
•	Try to answer every question.
•	Check your answers if you have time at the end.
PMT


--- Page Break ---

2
*P62456A0232*
	
BLANK PAGE
PMT


--- Page Break ---

3
*P62456A0332*
Turn over    
	
Answer ALL questions.
Write your answers in the spaces provided.
Some questions must be answered with a cross in a box 
.  If you change your mind about 
an answer, put a line through the box 
 and then mark your new answer with a cross 
.
1	 The primary structure of a protein determines its secondary structure and its 
three‑dimensional structure.
	
(a)	 Read through the following account of the primary structure of a protein.
(5)
	
	
Complete the account by writing the most appropriate word or words on the 
dotted lines.
	
	
The primary structure of a protein is the specific sequence of amino acids joined 
together by .............................................................................................. bonds.
	
	
These bonds are formed between the .............................................................................................. group of 
one amino acid and the .............................................................................................. group of an adjacent 
amino acid by a .............................................................................................. reaction.
	
	
These bonds are formed during the stage of protein synthesis  
called .............................................................................................. .
	
(b)	 The table describes the types of bond that hold the secondary and the 
three‑dimensional structures together.
	
	
Which type of bonding is true for each structure?
(2)
Structure
Hydrogen 
bonds only
Ionic 
bonds only
Both hydrogen 
and ionic bonds
Neither of 
these bonds
secondary structure
three‑dimensional structure
(Total for Question 1 = 7 marks)
PMT


--- Page Break ---

4
*P62456A0432*
	
2	 Most Bengal tigers are orange with black stripes but there is a very small number of 
Bengal tigers that are white with black stripes.
	
The photograph shows a white Bengal tiger with black stripes.
(Source: Caroline Wilcox)
	
White tiger offspring are produced by two Bengal tigers that each carry at least one 
recessive allele for a gene affecting coat colour.
	
The pedigree diagram shows the phenotypes in one family of tigers, bred in captivity.
Key
female orange tiger
female white tiger
male orange tiger
male white tiger
	
(a)	 The phenotype is affected by the genotype.
	
	
State what is meant by the term genotype.
(1)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

5
*P62456A0532*
Turn over    
	
	
(b)	 State the probability that the next tiger born to these two parents will be female.
(1)
....................................................................................................................................................................................................................................................................................
	
(c)	 Determine the expected phenotypic ratio of orange tigers to white tigers born to 
the parents shown in this pedigree diagram.
	
	
Use a genetic diagram to support your answer.
(3)
Answer ............................................................................................................................
	
(d)	 The incidence of white tigers in the wild is 1 in 10 000 Bengal tigers.
	
	
There are approximately 6000 Bengal tigers in captivity, 200 of which are white.
	
	
Calculate the incidence of white tigers in captivity.
(1)
Answer ..............................................................
(Total for Question 2 = 6 marks)
PMT


--- Page Break ---

6
*P62456A0632*
	
3	 The cardiac cycle is the sequence of events that occurs when the heart beats.
	
A typical cardiac cycle takes 0.86 seconds.
	
(a)	 The diagram illustrates the cardiac cycle.
Key
atrial systole
atrial diastole
ventricular systole
ventricular diastole
Cardiac 
cycle
	
	
(i)	 Which row of the table describes the atria and ventricles during atrial systole?
(1)
Atria
Ventricles
A
contracted
contracted
B
contracted
relaxed
C
relaxed
contracted
D
relaxed
relaxed
	
	
(ii)	 Explain why there is a delay of 0.01 seconds between atrial systole and 
ventricular systole.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

7
*P62456A0732*
Turn over    
	
	
	
(iii)	Using the information in the diagram, calculate the duration of 
ventricular systole in milliseconds.
	
	
	
Express your answer in standard form.
(2)
Answer .............................................................. ms
	
	
(iv)	State what proportion of the cardiac cycle is spent in ventricular diastole.
(1)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
(b)	 A typical cardiac cycle takes 0.86 seconds.
	
	
During exercise, the heart rate increases and the duration of the cardiac cycle decreases.
	
	
Calculate the increase in heart rate if the cardiac cycle decreases by 0.4 seconds.
(3)
Answer .............................................................. beats per minute
(Total for Question 3 = 9 marks)
PMT


--- Page Break ---

8
*P62456A0832*
	
4	 The polynucleotide DNA is composed of mononucleotides linked together.
	
Two polynucleotides form a DNA molecule.
	
(a)	 The diagram shows part of a DNA molecule.
P
Q
R
S
T
U
	
	
(i)	 Draw a circle around one mononucleotide that includes the base labelled R.
(1)
PMT


--- Page Break ---

9
*P62456A0932*
Turn over    
	
	
	
(ii)	 Which row of the table identifies the bonds labelled S, T and U?
(1)
S
T
U
A
hydrogen
phosphodiester
covalent
B
hydrogen
covalent
phosphodiester
C
phosphodiester
hydrogen
covalent
D
phosphodiester
covalent
hydrogen
	
	
(iii)	The base labelled P is adenine.
	
	
	
Which is the base labelled Q?
(1)
	
	
	
A	 cytosine
	
	
	
B	 guanine
	
	
	
C	 thymine
	
	
	
D	 uracil
PMT


--- Page Break ---

10
*P62456A01032*
	
	
(b)	 Meselson and Stahl carried out experiments that provided evidence for the 
semi‑conservative replication of DNA.
	
	
Heavy nitrogen (N15) and light nitrogen (N14) were used in these experiments.
	
	
The flow chart summarises part of one experiment performed by Meselson 
and Stahl.
Stage 1
Bacteria grown for several generations in a culture 
medium containing heavy nitrogen (N15)
Stage 2
Bacteria from stage 1 grown for one generation in a 
culture medium containing light nitrogen (N14)
Stage 3
 Bacteria from stage 2 grown for one generation in a 
culture medium containing light nitrogen (N14)
Stage 4
Bacteria from stage 3 grown for one generation in a 
culture medium containing light nitrogen (N14)
	
	
After each stage, a sample of DNA was taken from the bacteria and the DNA 
molecules separated using a density gradient in a tube.
	
	
The heavier DNA molecules form bands lower down the gradient than the lighter 
DNA molecules.
	
	
The height of each band is proportional to the percentage of DNA molecules in 
the sample.
PMT


--- Page Break ---

11
*P62456A01132*
Turn over    
	
	
	
(i)	 Complete the diagram to show the results of this experiment.
	
	
	
Use the dotted lines to help you to position the bands on the diagram.
	
	
	
The first one has been done for you.
(5)
DNA sample taken 
after stage 1
DNA sample taken 
after stage 2
DNA sample taken 
after stage 3
DNA sample taken 
after stage 4
PMT


--- Page Break ---

12
*P62456A01232*
	
	
	
(ii)	 The experiments of Meselson and Stahl disproved the dispersive theory of 
DNA replication.
	
	
	
The diagram shows the expected results if the dispersive theory was correct.
Appearance of bands 
on density gradient
Stage 1
One DNA molecule 
containing 
heavy nitrogen (N15)
Stage 2
Two DNA molecules 
containing 
heavy nitrogen (N15) and 
light nitrogen (N14)
	
	
	
Which diagram would show the bands of DNA molecules on the density 
gradient at stage 2, if the dispersive theory was correct?
(1)
A
B
C
D
(Total for Question 4 = 9 marks)
PMT


--- Page Break ---

13
*P62456A01332*
Turn over    
	
5	 Obesity increases the risk of cardiovascular disease (CVD).
	
One way to reduce obesity is to lose weight by changing eating habits.
	
(a)	 Name two obesity indicators used by scientists.
(1)
1.................................................................................................................................................................................................................................................................................
2.................................................................................................................................................................................................................................................................................
	
(b)	 Glucomannan is a dietary supplement claimed to aid weight loss.
	
	
Glucomannan is a branched polysaccharide similar in structure to amylopectin.
	
	
(i)	 Which glycosidic bonds are responsible for the branching in glucomannan?
(1)
	
	
	
A	 1‑4 only
	
	
	
B	 1‑6 only
	
	
	
C	 both 1‑4 and 1‑6
	
	
	
D	 neither 1‑4 nor 1‑6
	
	
(ii)	 In the presence of water, glucomannan swells to form a semi‑solid gel.
	
	
	
The diagram shows a stomach with glucomannan present and a stomach 
without glucomannan.
Key
food
glucomannan
	
	
	
Suggest how glucomannan aids weight loss.
(1)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

14
*P62456A01432*
	
	
	
(iii)	If glucomannan could be digested it would cause a gain in weight.
	
	
	
Explain why glucomannan could cause a gain in weight.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

15
*P62456A01532*
Turn over    
	
	
(c)	 A study compared weight loss in two groups of women.
	
	
One group of women had a low‑fat diet and the other group of women had a 
very low‑carbohydrate diet.
	
	
(i)	 The table shows the results of this study.
Number of weeks 
on the diet
Mean body mass of the group of women / kg
Group on the 
low‑fat diet
Group on the very 
low‑carbohydrate diet
0
92.5
91.1
2
90.6
88.3
4
89.9
87.5
6
89.0
85.6
8
88.8
84.5
10
88.3
84.1
12
88.2
83.0
	
	
	
Many studies claim that a low‑carbohydrate diet can result in two to three 
times as much weight loss as a low‑fat diet.
	
	
	
Determine the extent to which this study supports this claim.
(3)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

16
*P62456A01632*
	
	
	
(ii)	 Very low‑carbohydrate diets may increase cardiovascular risk factors.
	
	
	
Give two factors, other than weight loss, that should have been monitored in 
this study.
(2)
1.................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
2.................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 5 = 10 marks)
PMT


--- Page Break ---

17
*P62456A01732*
Turn over    
	
BLANK PAGE
PMT


--- Page Break ---

18
*P62456A01832*
	
6	 A gene contains the genetic code for the sequence of amino acids in a polypeptide chain.
	
The table shows the genetic codes found in DNA.
Genetic 
code
Amino 
acid
Genetic 
code
Amino 
acid
Genetic 
code
Amino 
acid
Genetic 
code
Amino acid
AAA 
AAG
Lysine
CAA 
CAG
Glutamine
GAA 
GAG
Glutamic 
acid
TAC 
TAT
Tyrosine
AAC 
AAT
Asparagine
CAT 
CAC
Histidine
GAC 
GAT
Aspartate
TCA 
TCC 
TCG 
TCT
Serine
ACA 
ACC 
ACG 
ACT
Threonine
CCA 
CCC 
CCG 
CCT
Proline
GCA 
GCC 
GCG 
GCT
Alanine
TGG
Tryptophan
AGA 
AGG
Arginine
CGA 
CGC 
CGG 
CGT
Arginine
GGA 
GGC 
GGG 
GGT
Glycine
TGC 
TGT
Cysteine
AGC 
AGT
Serine
CTA 
CTC 
CTG 
CTT
Leucine
GTA 
GTC 
GTG 
GTT
Valine
TTA 
TTG
Leucine
ATA 
ATC 
ATT
Isoleucine
TTC 
TTT
Phenylalanine
ATG
Methionine
	
The genetic codes TAA, TAG and TGA are stop codons, that do not code for amino acids.
PMT


--- Page Break ---

19
*P62456A01932*
Turn over    
	
	
*(a)	 Explain the nature of the genetic code.
	
	
Use information in the table to support your answer.
(6)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

20
*P62456A02032*
	
	
(b)	 The diagram shows the sequence of nucleotide bases in part of a DNA template 
(antisense) strand.
Number
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Base
A
T
G
G
C
T
T
G
C
C
C
G
A
T
C
C
T
A
	
	
(i)	 Give the sequence of amino acids that is coded for by these bases.
(1)
....................................................................................................................................................................................................................................................................................
	
	
(ii)	 Explain the possible effects on a protein if there is a substitution mutation in 
the 9th base in this DNA strand.
	
	
	
Use information in the table to support your answer.
(5)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 6 = 12 marks)
PMT


--- Page Break ---

21
*P62456A02132*
Turn over    
	
BLANK PAGE
PMT


--- Page Break ---

22
*P62456A02232*
	
7	 Warfarin is used in the treatment of cardiovascular disease.
	
Warfarin inhibits the synthesis of prothrombin.
	
(a)	 Describe the role of prothrombin in the blood clotting process.
(3)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
(b)	 Which type of treatment is warfarin?
(1)
	
	
A	 anticoagulant
	
	
B	 antihypertensive
	
	
C	 platelet inhibitor
	
	
D	 statin
PMT


--- Page Break ---

23
*P62456A02332*
Turn over    
	
	
(c)	 Reduced vitamin K is needed for the synthesis of prothrombin.
	
	
An enzyme, vitamin K epoxide reductase (VKOR), converts vitamin K to reduced 
vitamin K.
	
	
The diagram shows this conversion.
VKOR
vitamin K
reduced vitamin K
	
	
(i)	 The diagrams show the structures of warfarin and vitamin K.
OH
O
O
O
Warfarin
O
O
Vitamin K
	
	
	
Using the information in the diagrams, suggest why warfarin inhibits the 
synthesis of prothrombin.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

24
*P62456A02432*
	
	
	
(ii)	 Suggest why people taking warfarin have to avoid eating foods that contain a 
high concentration of vitamin K.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

25
*P62456A02532*
Turn over    
	
	
(d)	 Other drugs are available that work in a similar way to warfarin.
	
	
The diagram shows one study to compare the effect of warfarin with drug X.
Two groups of people, Group A and Group B
Group A given warfarin and vitamin K and 
Group B given drug X and vitamin K
Levels of prothrombin measured in each group
	
	
Explain how this study should be designed so that the effectiveness of these two 
drugs can be compared.
(4)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 7 = 12 marks)
PMT


--- Page Break ---

26
*P62456A02632*
	
8	 Low‑density lipoproteins (LDLs) transport lipids around the body in the blood.
	
Low‑density lipoproteins can result in the development of atherosclerosis.
	
They can be absorbed into the endothelial cells lining arteries and broken down by 
free radicals.
	
The diagram shows a low‑density lipoprotein containing cholesterol.
phospholipid 
and protein
triglyceride
cholesterol
	
(a)	 Compare and contrast the structure of a triglyceride and a phospholipid.
(3)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

27
*P62456A02732*
Turn over    
	
	
(b)	 Explain why the properties of LDLs enable cholesterol to be transported in 
the blood.
(3)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
(c)	 The diameters of LDLs range from 19 nm to 24 nm.
	
	
The table shows some information about LDLs.
Diameter of LDL 
/ nm
Volume of LDL 
/ nm3
Volume of cholesterol 
/ nm3
Ratio of LDL volume 
to cholesterol volume
19
3590
523
7 : 1
24
523
	
	
(i)	 Complete the table by calculating the volume of LDL and the ratio of 
LDL volume to cholesterol volume.
	
	
	
Use the formula v = 4
3 πr3
(3)
PMT


--- Page Break ---

28
*P62456A02832*
	
	
	
*(ii)	 The graph shows the relationship between LDLs, high‑density 
lipoproteins (HDLs) and the risk of CVD.
Level of HDL in 
blood = 0.65 a.u.
Risk of CVD
Level of LDL in blood
Level of HDL in 
blood = 1.16 a.u.
Level of HDL in 
blood = 1.68 a.u.
Level of HDL in 
blood = 2.20 a.u.
	
	
	
Explain why measuring only the level of LDL in the blood is not a reliable 
predictor of CVD.
	
	
	
Use the graph, all the information in this question and your own knowledge 
to support your answer.
(6)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

29
*P62456A02932*
	
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
(Total for Question 8 = 15 marks)
TOTAL FOR PAPER = 80 MARKS
PMT


--- Page Break ---

30
*P62456A03032*
	
BLANK PAGE
PMT


--- Page Break ---

31
*P62456A03132*
	
BLANK PAGE
PMT


--- Page Break ---

32
*P62456A03232*
	
BLANK PAGE
PMT
